BIB vs. VTI
BIB (ProShares Ultra Nasdaq Biotechnology) and VTI (Vanguard Total Stock Market ETF) are both exchange-traded funds - BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%), while VTI is a Large Cap Blend Equities fund tracking the CRSP US Total Market Index. Both are passively managed. Over the past 10 years, BIB returned 9.71%/yr vs 15.14%/yr for VTI. A 0.65 correlation means they provide meaningful diversification when combined. BIB charges 0.95%/yr vs 0.03%/yr for VTI.
Performance
BIB vs. VTI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIB achieves a 12.50% return, which is significantly higher than VTI's 8.82% return. Over the past 10 years, BIB has underperformed VTI with an annualized return of 9.71%, while VTI has yielded a comparatively higher 15.14% annualized return.
BIB
- 1D
- 1.97%
- 1M
- 9.49%
- YTD
- 12.50%
- 6M
- 8.62%
- 1Y
- 100.86%
- 3Y*
- 19.65%
- 5Y*
- -0.74%
- 10Y*
- 9.71%
VTI
- 1D
- -1.39%
- 1M
- -0.84%
- YTD
- 8.82%
- 6M
- 7.71%
- 1Y
- 24.22%
- 3Y*
- 20.62%
- 5Y*
- 11.90%
- 10Y*
- 15.14%
BIB vs. VTI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 12.50% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
VTI Vanguard Total Stock Market ETF | 8.82% | 17.10% | 23.81% | 26.05% | -19.52% | 25.68% | 21.08% | 30.67% | -5.23% | 21.21% |
Correlation
The correlation between BIB and VTI is 0.50, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.61 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Apr 8, 2010 | 0.65 |
The correlation between BIB and VTI shifts across timeframes, from 0.50 (1 year) to 0.65 (all time), reflecting how their relationship changes across market environments.
BIB vs. VTI - Sectors Allocation Comparison
Sectors
BIB
VTI
Healthcare
Financial Services
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
BIB
VTI
Financial Services
BIB
VTI
Basic Materials
BIB
-
VTI
Communication Services
BIB
-
VTI
Consumer Cyclical
BIB
-
VTI
Consumer Defensive
BIB
-
VTI
Energy
BIB
-
VTI
Industrials
BIB
-
VTI
Real Estate
BIB
-
VTI
Technology
BIB
-
VTI
Utilities
BIB
-
VTI
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIB vs. VTI — Risk / Return Rank
BIB
VTI
BIB vs. VTI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and Vanguard Total Stock Market ETF (VTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIB | VTI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.61 | ||
| Sortino ratioReturn per unit of downside risk | +0.48 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.34 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 5.99 | 2.73 | +3.27 |
| Martin ratioReturn relative to average drawdown | 18.30 | 12.14 | +6.16 |
Loading charts...
Drawdowns
BIB vs. VTI - Drawdown Comparison
The maximum BIB drawdown since its inception was -67.24%, which is greater than VTI's maximum drawdown of -55.45%. Use the drawdown chart below to compare losses from any high point for BIB and VTI.
Loading charts...
Drawdown Indicators
| BIB | VTI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.24% | -55.45% | -11.79% |
Max Drawdown (1Y)Largest decline over 1 year | -16.92% | -8.92% | -8.00% |
Max Drawdown (3Y)Largest decline over 3 years | -45.30% | -19.30% | -26.00% |
Max Drawdown (5Y)Largest decline over 5 years | -65.86% | -25.36% | -40.50% |
Max Drawdown (10Y)Largest decline over 10 years | -66.20% | -35.00% | -31.20% |
Current DrawdownCurrent decline from peak | -17.29% | -2.85% | -14.44% |
Average DrawdownAverage peak-to-trough decline | -32.71% | -8.01% | -24.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.53% | 2.00% | +3.53% |
Volatility
BIB vs. VTI - Volatility Comparison
ProShares Ultra Nasdaq Biotechnology (BIB) has a higher volatility of 13.56% compared to Vanguard Total Stock Market ETF (VTI) at 4.95%. This indicates that BIB's price experiences larger fluctuations and is considered to be riskier than VTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIB | VTI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.56% | 4.95% | +8.61% |
Volatility (6M)Calculated over the trailing 6-month period | 31.65% | 10.05% | +21.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.43% | 12.83% | +27.60% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.60% | 17.51% | +26.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.39% | 18.32% | +28.07% |
BIB vs. VTI - Expense Ratio Comparison
BIB has a 0.95% expense ratio, which is higher than VTI's 0.03% expense ratio.
Dividends
BIB vs. VTI - Dividend Comparison
BIB's dividend yield for the trailing twelve months is around 0.55%, less than VTI's 1.04% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.55% | 0.77% | 1.69% | 0.07% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VTI Vanguard Total Stock Market ETF | 1.04% | 1.12% | 1.27% | 1.44% | 1.66% | 1.21% | 1.42% | 1.78% | 2.04% | 1.71% | 1.92% | 1.98% |
Frequently Asked Questions
BIB and VTI have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIB has higher volatility (13.56%) compared to VTI (4.95%). In terms of maximum drawdown, BIB dropped -67.24% vs VTI's -55.45%.
On 10-year performance, VTI leads with 15.14% vs 9.71% for BIB. On fees, VTI is cheaper at 0.03% per year. On volatility, VTI has been the lower-risk option at 4.95%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, VTI has performed better with a 15.14% return vs 9.71%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
VTI is cheaper with a 0.03% expense ratio, compared with 0.95% for BIB.
VTI has the higher dividend yield at 1.04%, compared with 0.55% for BIB.
BIB is categorized as Leveraged Equities, while VTI is Large Cap Blend Equities. BIB tracks NASDAQ Biotechnology Index (200%), while VTI tracks CRSP US Total Market Index. They also come from different issuers: ProShares and Vanguard. Their fees differ too: 0.95% for BIB and 0.03% for VTI.
BIB currently has the higher Sharpe Ratio (2.51 vs 1.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIB and VTI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer